Literature DB >> 18317504

MicroRNA target detection and analysis for genes related to breast cancer using MDLcompress.

Scott C Evans1, Antonis Kourtidis, T Stephen Markham, Jonathan Miller, Douglas S Conklin, Andrew S Torres.   

Abstract

We describe initial results of miRNA sequence analysis with the optimal symbol compression ratio (OSCR) algorithm and recast this grammar inference algorithm as an improved minimum description length (MDL) learning tool: MDLcompress. We apply this tool to explore the relationship between miRNAs, single nucleotide polymorphisms (SNPs), and breast cancer. Our new algorithm outperforms other grammar-based coding methods, such as DNA Sequitur, while retaining a two-part code that highlights biologically significant phrases. The deep recursion of MDLcompress, together with its explicit two-part coding, enables it to identify biologically meaningful sequence without needlessly restrictive priors. The ability to quantify cost in bits for phrases in the MDL model allows prediction of regions where SNPs may have the most impact on biological activity. MDLcompress improves on our previous algorithm in execution time through an innovative data structure, and in specificity of motif detection (compression) through improved heuristics. An MDLcompress analysis of 144 over expressed genes from the breast cancer cell line BT474 has identified novel motifs, including potential microRNA (miRNA) binding sites that are candidates for experimental validation.

Entities:  

Year:  2007        PMID: 18317504      PMCID: PMC3171339          DOI: 10.1155/2007/43670

Source DB:  PubMed          Journal:  EURASIP J Bioinform Syst Biol        ISSN: 1687-4145


  23 in total

1.  DNACompress: fast and effective DNA sequence compression.

Authors:  Xin Chen; Ming Li; Bin Ma; John Tromp
Journal:  Bioinformatics       Date:  2002-12       Impact factor: 6.937

2.  Conserved seed pairing, often flanked by adenosines, indicates that thousands of human genes are microRNA targets.

Authors:  Benjamin P Lewis; Christopher B Burge; David P Bartel
Journal:  Cell       Date:  2005-01-14       Impact factor: 41.582

3.  Pervasive regulation of Drosophila Notch target genes by GY-box-, Brd-box-, and K-box-class microRNAs.

Authors:  Eric C Lai; Bergin Tam; Gerald M Rubin
Journal:  Genes Dev       Date:  2005-04-15       Impact factor: 11.361

4.  Potent and specific genetic interference by double-stranded RNA in Caenorhabditis elegans.

Authors:  A Fire; S Xu; M K Montgomery; S A Kostas; S E Driver; C C Mello
Journal:  Nature       Date:  1998-02-19       Impact factor: 49.962

5.  A genetic screen implicates miRNA-372 and miRNA-373 as oncogenes in testicular germ cell tumors.

Authors:  P Mathijs Voorhoeve; Carlos le Sage; Mariette Schrier; Ad J M Gillis; Hans Stoop; Remco Nagel; Ying-Poi Liu; Josyanne van Duijse; Jarno Drost; Alexander Griekspoor; Eitan Zlotorynski; Norikazu Yabuta; Gabriella De Vita; Hiroshi Nojima; Leendert H J Looijenga; Reuven Agami
Journal:  Cell       Date:  2006-03-24       Impact factor: 41.582

6.  Microarray analysis shows that some microRNAs downregulate large numbers of target mRNAs.

Authors:  Lee P Lim; Nelson C Lau; Philip Garrett-Engele; Andrew Grimson; Janell M Schelter; John Castle; David P Bartel; Peter S Linsley; Jason M Johnson
Journal:  Nature       Date:  2005-01-30       Impact factor: 49.962

7.  cDNA microarray analysis of genes associated with ERBB2 (HER2/neu) overexpression in human mammary luminal epithelial cells.

Authors:  Alan Mackay; Chris Jones; Tim Dexter; Ricardo L A Silva; Karen Bulmer; Allison Jones; Peter Simpson; Robert A Harris; Parmjit S Jat; A Munro Neville; Luiz F L Reis; Sunil R Lakhani; Michael J O'Hare
Journal:  Oncogene       Date:  2003-05-01       Impact factor: 9.867

8.  Identification and validation of an ERBB2 gene expression signature in breast cancers.

Authors:  François Bertucci; Nathalie Borie; Christophe Ginestier; Agnès Groulet; Emmanuelle Charafe-Jauffret; José Adélaïde; Jeannine Geneix; Loïc Bachelart; Pascal Finetti; Alane Koki; Fabienne Hermitte; Jacques Hassoun; Stéphane Debono; Patrice Viens; Vincent Fert; Jocelyne Jacquemier; Daniel Birnbaum
Journal:  Oncogene       Date:  2004-04-01       Impact factor: 9.867

9.  Prediction of mammalian microRNA targets.

Authors:  Benjamin P Lewis; I-hung Shih; Matthew W Jones-Rhoades; David P Bartel; Christopher B Burge
Journal:  Cell       Date:  2003-12-26       Impact factor: 41.582

10.  Principles of microRNA-target recognition.

Authors:  Julius Brennecke; Alexander Stark; Robert B Russell; Stephen M Cohen
Journal:  PLoS Biol       Date:  2005-03       Impact factor: 8.029

View more
  4 in total

Review 1.  MicroRNA polymorphisms: the future of pharmacogenomics, molecular epidemiology and individualized medicine.

Authors:  Prasun J Mishra; Joseph R Bertino
Journal:  Pharmacogenomics       Date:  2009-03       Impact factor: 2.533

2.  MicroRNAs: Potential biomarkers in cancer.

Authors:  G P George; Rama Devi Mittal
Journal:  Indian J Clin Biochem       Date:  2010-02-10

3.  Identifying a polymorphic 'switch' that influences miRNAs' regulation of a myasthenia gravis risk pathway.

Authors:  Lili Yang; Jianjian Wang; Xuesong Sun; Yuze Cao; Shangwei Ning; Huixue Zhang; Lixia Chen; Ronghong Li; Qinghua Tian; Lihua Wang; Weizhi Wang; Xia Li
Journal:  PLoS One       Date:  2014-08-12       Impact factor: 3.240

4.  Optimal reference sequence selection for genome assembly using minimum description length principle.

Authors:  Bilal Wajid; Erchin Serpedin; Mohamed Nounou; Hazem Nounou
Journal:  EURASIP J Bioinform Syst Biol       Date:  2012-11-27
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.